| Between the court and the clinic: lawsuits for medicines and the right to health in Brazil J Biehl, JJ Amon, MP Socal, A Petryna Health & Hum. Rts. 14, 36, 2012 | 179 | 2012 |
| The judicialization of health and the quest for state accountability: evidence from 1,262 lawsuits for access to medicines in southern Brazil J Biehl, MP Socal, JJ Amon Health and human rights 18 (1), 209, 2016 | 140 | 2016 |
| A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm CRM Rieder, P Schestatsky, MP Socal, TL Monte, D Fricke, J Costa, ... Clinical neuropharmacology 30 (1), 39-42, 2007 | 79 | 2007 |
| The pandemic and the supply chain: gaps in pharmaceutical production and distribution MP Socal, JM Sharfstein, JA Greene American journal of public health 111 (4), 635-639, 2021 | 58 | 2021 |
| Using external reference pricing in Medicare Part D to reduce drug price differentials with other countries SY Kang, MJ DiStefano, MP Socal, GF Anderson Health Affairs 38 (5), 804-811, 2019 | 38 | 2019 |
| Judicialization 2.0: Understanding right-to-health litigation in real time J Biehl, MP Socal, V Gauri, D Diniz, M Medeiros, G Rondon, JJ Amon Global public health 14 (2), 190-199, 2019 | 34 | 2019 |
| Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the southern network on adverse reactions CL Bennett, D Focosi, MP Socal, JC Bian, C Nabhan, WJ Hrushesky, ... The Lancet Haematology 8 (8), e593-e604, 2021 | 32 | 2021 |
| Favorable formulary placement of branded drugs in Medicare prescription drug plans when generics are available MP Socal, G Bai, GF Anderson JAMA internal medicine 179 (6), 832-833, 2019 | 30 | 2019 |
| Comparative approaches to drug pricing SY Kang, G Bai, MJ DiStefano, MP Socal, F Yehia, GF Anderson Annual review of public health 41, 499-512, 2020 | 29 | 2020 |
| Clinical and epidemiological factors associated with mortality in Parkinson’s disease in a Brazilian cohort GC Fernandes, MP Socal, AFS Schuh, CRM Rieder Parkinson’s disease 2015, 2015 | 29 | 2015 |
| Occupational pesticide exposure and the risk of death in patients with Parkinson’s disease: an observational study in southern Brazil M Schneider Medeiros, S P. Reddy, M P. Socal, AF Schumacher-Schuh, ... Environmental Health 19, 1-8, 2020 | 27 | 2020 |
| Prevalência da exposição pré-natal à cocaína em uma amostra de recém-nascidos de um hospital geral universitário GB Cunha, NT Rotta, AR Silva, AL Dieder, AL Wolf, C Moser, FF Silva, ... Jornal de Pediatria 77, 369-373, 2001 | 25 | 2001 |
| Patient selection after mandatory bundled payments for hip and knee replacement: limited evidence of lemon-dropping or cherry-picking CJ Humbyrd, SS Wu, AJ Trujillo, MP Socal, GF Anderson JBJS 102 (4), 325-331, 2020 | 23 | 2020 |
| Biosimilar uptake in Medicare Part B varied across hospital outpatient departments and physician practices: the case of filgrastim MP Socal, KE Anderson, A Sen, G Bai, GF Anderson Value in Health 23 (4), 481-486, 2020 | 22 | 2020 |
| Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians MP Socal, H Bock, K Michelin-Tirelli, A Hilbig, ML Saraiva-Pereira, ... Parkinsonism & related disorders 15 (1), 76-78, 2009 | 22 | 2009 |
| Market exclusivity for drugs with multiple orphan approvals (1983–2017) and associated budget impact in the US WV Padula, S Parasrampuria, MP Socal, RM Conti, GF Anderson PharmacoEconomics 38, 1115-1121, 2020 | 17 | 2020 |
| Right-to-medicines litigation and universal health coverage: Institutional determinants of the judicialization of health in Brazil MP Socal, JJ Amon, J Biehl Health and human rights 22 (1), 221, 2020 | 15 | 2020 |
| Limited distribution networks stifle competition in the generic and biosimilar drug industries L Karas, KM Shermock, C Proctor, M Socal, GF Anderson Am J Manag Care 24 (4), e122-e127, 2018 | 15 | 2018 |
| Implementation of Brazilian Guidelines for Botulinum Toxin: a three-year follow-up of a cost-reduction strategy in the public health system of Rio Grande do Sul, Brazil PD Picon, FC Guarany, MP Socal, MP Leal, EA Laporte, P Schestatsky, ... Oral presentation 4, 2007 | 15 | 2007 |
| Reducing branded prescription drug prices: A review of policy options GC Alexander, J Ballreich, MP Socal, T Karmarkar, A Trujillo, J Greene, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (11 …, 2017 | 14 | 2017 |
